EPIC PHARMA LLC FDA Approval ANDA 076347

ANDA 076347

EPIC PHARMA LLC

FDA Drug Application

Application #076347

Application Sponsors

ANDA 076347EPIC PHARMA LLC

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORALEQ 2MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE
002TABLET;ORALEQ 4MG BASE0TIZANIDINE HYDROCHLORIDETIZANIDINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2002-10-11
LABELING; LabelingSUPPL4AP2007-01-12
LABELING; LabelingSUPPL5AP2007-03-02
LABELING; LabelingSUPPL6AP2007-04-10
LABELING; LabelingSUPPL8AP2016-07-18STANDARD

Submissions Property Types

SUPPL8Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

EPIC PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76347
            [companyName] => EPIC PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 2MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"TIZANIDINE HYDROCHLORIDE","activeIngredients":"TIZANIDINE HYDROCHLORIDE","strength":"EQ 4MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TIZANIDINE HYDROCHLORIDE","submission":"TIZANIDINE HYDROCHLORIDE","actionType":"EQ 2MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"TIZANIDINE HYDROCHLORIDE","submission":"TIZANIDINE HYDROCHLORIDE","actionType":"EQ 4MG BASE","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.